The buzz: A healthier future.
On Pharma and Technology – Part 1 (Sept. 17, 2014), we discussed the need for pharma to move more quickly to introduce safe, cost-effective drugs that respond effectively to cancer, Ebola, and other chronic and urgent diseases.
Today on Part 2, we explore how pharma and medical devices companies are working together to surmount health market hurdles in preparation for a healthier global future.
How soon will they be able to glean life-saving insights by connecting the dots among scientific, clinical, genomic, and patient therapy data?
Will new collaboration networks add value to clinical trials and post-drug-launches?
Are they optimistic that these and other innovations will yield urgently-needed improvements?
The experts speak.
Ashish Goel, Infosys: “Change is not a destination, just as hope is not a strategy.” (Former New York City Mayor Rudy Giuliani)
Alan S. Louie, Ph.D, IDC Health Insights: “Choose a job you love, and you will never have to work a day in your life.” (Confucius)
Joe Miles, SAP: “Test fast, fail fast, adjust fast.” (Tom Peters)
Join us for Pharma and Technology: Higher Outcomes, Lower Costs – Part 2.